keyword
https://read.qxmd.com/read/38490888/sea-2024-standards-for-global-control-of-vascular-risk
#1
José María Mostaza, Xavier Pintó, Pedro Armario, Luis Masana, José T Real, Pedro Valdivielso, Teresa Arrobas-Velilla, Ramón Baeza-Trinidad, Pilar Calmarza, Jesús Cebollada, Miguel Civera-Andrés, José I Cuende Melero, José L Díaz-Díaz, Javier Espíldora-Hernández, Jacinto Fernández Pardo, Carlos Guijarro, Carles Jericó, Martín Laclaustra, Carlos Lahoz, José López-Miranda, Sergio Martínez-Hervás, Ovidio Muñiz-Grijalvo, Juan A Páramo, Vicente Pascual, Juan Pedro-Botet, Pablo Pérez-Martínez, José Puzo
One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to the knowledge, prevention and treatment of vascular diseases, which are the leading cause of death in Spain and entail a high degree of disability and health expenditure. Atherosclerosis is a multifactorial disease and its prevention requires a global approach that takes into account the associated risk factors. This document summarises the current evidence and includes recommendations for patients with established vascular disease or at high vascular risk: it reviews the symptoms and signs to evaluate, the laboratory and imaging procedures to request routinely or in special situations, and includes the estimation of vascular risk, diagnostic criteria for entities that are vascular risk factors, and general and specific recommendations for their treatment...
March 14, 2024: Clínica e Investigación en Arteriosclerosis
https://read.qxmd.com/read/38161101/clinical-epidemiological-analysis-of-patients-with-elevated-lipoprotein-a-in-a-third-level-hospital
#2
JOURNAL ARTICLE
Manuel García de Prada, Ramón Costa Segovia, Marta de Castro Martínez, Nuria Valdeolivas Hidalgo, María Belén Sánchez López, Agustín Blanco Echevarría
OBJECTIVE: The objective of the study is to describe the clinical and epidemiological characteristics of our patients with elevated Lp(a). MATERIALS AND METHODS: A descriptive cross-sectional study was conducted on 316 patients with elevated Lp(a) (>125 nmol/L) in a random sample between January and August 2022. We measured epidemiological, anthropometric, clinical and laboratory variables (lipid metabolism parameters, carbohydrates and hormones). RESULTS: Mean age of our sample subject's was 59 ± 15 years with 56% males...
December 30, 2023: Clínica e Investigación en Arteriosclerosis
https://read.qxmd.com/read/37116971/hyperthyroidism-and-cardiovascular-risk-factors-a-nationwide-study
#3
JOURNAL ARTICLE
Pedro Iglesias, Juan J Díez
BACKGROUND: Thyroid hormones (THs) have important effects on cardiovascular (CV) physiology. Thyroid disorders are accompanied by serious effects on the CV system. OBJECTIVE: To study the association between hyperthyroidism and the main CV risk factors (CVRFs), such as hypertension, dyslipidemia, diabetes and smoking in the Spanish population. MATERIAL AND METHODS: An observational, retrospective, non-interventional study was performed using the statistical portal of the Spanish Ministry of Health associated with the Base de Datos Clínicos de Atención Primaria (BDCA) database...
April 2023: Endocrinología, diabetes y nutrición
https://read.qxmd.com/read/36933696/achievement-of-long-term-lipid-targets-in-a-cohort-of-patients-with-acute-coronary-syndrome-in-real-world-clinical-practice
#4
JOURNAL ARTICLE
C Baldeón Conde, N Royuela Martínez, C García Ibarbia, A R Guerra Ruiz, I Olavarri Miguel, M Cobo Belaustegui, B Alio Lavín, F J González Vilchez, J M de la Torre Hernández, J L Hernández Hernández
INTRODUCTION AND OBJECTIVES: According to the recent European epidemiological studies, the degree of lipid control in patients with very high vascular risk is suboptimal. This study analyzes the epidemiological characteristics, cardiovascular risk factors, lipid profile, recurrence, and degree of achievement of long-term lipid targets, according to the ESC/EAS Guidelines, in a cohort of patients with acute coronary syndrome (ACS) in a real-world clinical practice setting. METHODS: This work is a retrospective cohort study of patients diagnosed with ACS admitted to the Coronary Unit of a tertiary hospital from January 1, 2012 to December 31, 2015 and followed-up on until March 2022...
March 16, 2023: Revista Clínica Espanõla
https://read.qxmd.com/read/36889989/remnant-cholesterol-vascular-risk-and-prevention-of-atherosclerosis
#5
REVIEW
Xavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán
In patients who have achieved optimal LDL-C control, there remains a residual risk of atherothrombotic cardiovascular disease (ACVD) related to alterations in lipid metabolism, where alterations in triglyceride-rich lipoproteins and the cholesterol they contain, called remnant cholesterol, play a major role. Remnant cholesterol has an association with residual risk of ACVD that is independent of LDL-C and has been demonstrated in epidemiological and Mendelian randomisation studies, and in analyses of clinical trials of lipid-lowering drugs...
March 6, 2023: Clínica e Investigación en Arteriosclerosis
https://read.qxmd.com/read/36764745/galipdia-study-reaching-lipid-targets-in-a-population-with-type-2-diabetes-t2dm-from-the-northwest-of-spain
#6
JOURNAL ARTICLE
Rocío Villar-Taibo, Eva Fernández-Rodríguez, Cristina Tejera-Pérez, Carmen Díaz-Ortega, Paula Sánchez-Sobrino, Regina Palmeiro-Carballeira, Nazareth Rodríguez-Novo, Gemma Rodríguez-Carnero, Iria Pinal-Osorio, Laura Cotovad-Bellas, Olaia Díaz-Trastoy, Beatriz Mantiñán-Gil, Paula Álvarez-Castro, Paula Andújar Plata, Inés Seoane-Cruz, Alma Prieto-Tenreiro, Rosa Argüeso Armesto, Antía Fernández-Pombo, Ana Sánchez-Bao, Alfonso Vidal-Casariego
AIM: To assess the degree of compliance with the European ESC/EAS 2016 and 2019 dyslipidaemia guidelines in patients with type 2 diabetes mellitus (T2DM). METHODS: Multicentre retrospective cross-sectional study, conducted in 380 adults with T2DM and dyslipidaemia in 7 Spanish health areas. INCLUSION CRITERIA: minimum follow-up of one year in Endocrinology Units, at least one visit in 2020 and a lipid profile measurement in the last 3 months...
January 2023: Endocrinología, diabetes y nutrición
https://read.qxmd.com/read/36717323/prevalence-of-atherogenic-dyslipidemia-related-factors-and-level-of-lipid-control-in-the-general-population-of-galicia-galipemias-study
#7
JOURNAL ARTICLE
Carlos Názara, Rosa M Argüeso, Juan Pedro-Botet, Xavier Pintó, Jesús Millán, Marta Pena Seijo, Pablo A Fernández, M Eugenia Ameneiros, Alberto Del Alamo, Avelino Rodríguez, José Antonio Díaz-Peromingo, María Rosa Vázquez Freire, Javier Muñiz, Teresa R Pérez-Castro, José Luis Díaz-Díaz, Antonio Pose Reino
OBJECTIVES: GALIPEMIAS is a study designed to establish the prevalence of familial dyslipidemia in the general population of Galicia. The objective of the present study was to assess the prevalence of atherogenic dyslipidemia (AD), its relationship with other cardiovascular risk (CVR) factors, and the degree of lipid control. METHODS: Cross-sectional study carried out in the general population over 18 years of age residing in Galicia and with a health card from the Galician Health Service (N=1,000)...
January 28, 2023: Clínica e Investigación en Arteriosclerosis
https://read.qxmd.com/read/36641361/evolocumab-as-treatment-in-lorlatinib-related-hyperlipidemia
#8
JOURNAL ARTICLE
Laura Pérez Alonso, Raquel Cervera Calero, María Ángeles Campos Fernández de Sevilla, Miguel Ángel Moreno Palanco, Jorge Francisco Gómez Cerezo
Anti-PCSK9 monoclonal antibodies have reduced the risk of cardiovascular events in patients with atheroesclerosis cardiovascular disease. However, its use has not been described in hyperlipidemia associated with lorlatinib, a third-generation ALK tyrosin kinasa inhibitor approved as treatment for ALK-positive non-small cell lung cancer.
January 12, 2023: Clínica e Investigación en Arteriosclerosis
https://read.qxmd.com/read/36436477/-overcoming-the-barriers-in-the-approach-of-the-chronic-patient
#9
JOURNAL ARTICLE
V Gasull Molinera, J A Divison Garrote, A Díaz Rodríguez, M Frías Vargas
At least one in three adults has multiple chronic conditions. The assistance of patients with chronic conditions is mandatory. This is one of the main tasks of the primary care physicians. The approach in these patients is challenging, as there are many barriers at different levels (sanitary system, healthcare professionals and patients). In addition, COVID-19 pandemic has worsened this situation even more. Therefore, it is necessary to take actions that try to improve this state. For this purpose, with the aim to find solutions/recommendations that may be helpful to attain a better diagnosis, treatment and follow-up of patients with chronic diseases, a group of experts of SEMERGEN have tried to identify the problems in the attention to these patients, searching for potential solutions and areas of improvement...
March 2023: Semergen
https://read.qxmd.com/read/36400610/nutritional-recommendations-in-the-prevention-and-treatment-of-atherogenic-dyslipidemia
#10
Vicente Pascual, José Luis Díaz, Jesús Millán Nuñez-Cortés, Pablo Pérez-Martínez
The incorporation of a healthy diet, regular physical exercise and smoking cessation are the initial measures to reduce cardiovascular risk in patients with atherogenic dyslipidemia. In these patients, the nutritional quality of their diet should be improved, replacing foods with a greater atherogenic effect for others with a healthier effect. There is strong evidence that plant-based dietary patterns, low in saturated fatty acids, cholesterol and sodium, with a high content of fiber, potassium and unsaturated fatty acids, are beneficial and reduce the expression of cardiovascular risk factors...
November 15, 2022: Clínica e Investigación en Arteriosclerosis
https://read.qxmd.com/read/36347797/prevalence-and-risk-factors-associated-with-different-comorbidities-in-obese-children-and-adolescents
#11
JOURNAL ARTICLE
Juan Pablo López-Galisteo, Teresa Gavela-Pérez, Francisco Javier Mejorado-Molano, Pilar Pérez-Segura, Isabel Aragón-Gómez, Carmen Garcés, Leandro Soriano-Guillén
INTRODUCTION: Different obesity-related comorbidities already present in childhood, such as: vitamin D deficiency, impaired carbohydrate metabolism, dyslipidaemia, arterial hypertension and non-alcoholic steatohepatitis. In this study, we aim to analyse the prevalence of comorbidities and to determine the predictive factors that affect these comorbidities. MATERIAL AND METHODS: Anthropometric, demographic and biochemical variables were collected from obese patients between six and 18 years of age...
November 5, 2022: Endocrinología, diabetes y nutrición
https://read.qxmd.com/read/36336553/smartlab-2-0-in-cardiovascular-prevention-of-atherogenic-dyslipidemia
#12
JOURNAL ARTICLE
Raquel Galván Toribio, Teresa Arrobas Velilla, Cristóbal Morales Porillo, Miguel Ángel Rico, Mar Martínez Quesada, Antonio León Justel
INTRODUCTION: SmartLab 2.0 is an innovative concept of multidisciplinary collaboration between the clinical laboratory and the diabetes day unit that was born with the aim of identifying patients at high cardiovascular risk who require priority attention, such as patients with atherogenic dyslipidemia, in order to create a cardiovascular prevention strategy. OBJECTIVE: Implementation in the Laboratory Information System (LIS) of an automated biochemical algorithm for the identification of patients with atherogenic dyslipidemia in routine analyses and priority referral to the diabetes day unit...
November 3, 2022: Clínica e Investigación en Arteriosclerosis
https://read.qxmd.com/read/35700474/-nutrigenetics-potentials-and-applications-in-cardiovascular-diseases-and-associated-risk-factors
#13
JOURNAL ARTICLE
Maria Daniela Defagó, Aldo Renato Eynard
Introduction: From nutrigenetics, the genetic variation to dietary response, it is possible to understand and modulate the clinical response conditioned by the genotype by the diet. Objetive: to explore the bibliographic evidence on the potential of nutrigenetics in the approach and treatment of cardiovascular diseases (CVD) and associated risk factors. Materials and methods: a systematic search was carried out in the electronic databases MEDLINE, EMBASE and Google Scholar...
June 6, 2022: Revista de la Facultad de Ciencias Médicas
https://read.qxmd.com/read/35654677/dyslipidemia-treatment-strategies-in-primary-and-secondary-prevention-dyslipemia-registry-of-the-spanish-arteriosclerosis-society
#14
JOURNAL ARTICLE
Victoria Marco-Benedí, Ana M Bea, Rosa M Sánchez Hernández, Núria Plana, Pedro Valdivielso, Fernando Civeira
INTRODUCTION: Clinical studies show that patients with high cardiovascular risk are still far from reaching the therapeutic objectives, especially of the levels of LDL cholesterol. If the management of these patients in specialized units differs from other scenarios is known. PATIENTS AND METHODS: 61 certified Lipid Units were selected in the Registry of Dyslipemias of the Spanish Arteriosclerosis Society for the collection of study data. The study included 3958 subjects >18 years of age who met the criteria for hypercholesterolemia (LDL cholesterol ≥160 mg/dL or non-HDL cholesterol ≥190 mg/dL) without familial hypercholesterolemia...
2022: Clínica e Investigación en Arteriosclerosis
https://read.qxmd.com/read/35090775/sea-2022-standards-for-global-control-of-cardiovascular-risk
#15
JOURNAL ARTICLE
Jose Maria Mostaza, Xavier Pintó, Pedro Armario, Luis Masana, José T Real, Pedro Valdivielso, Teresa Arrobas-Velilla, Ramón Baeza-Trinidad, Pilar Calmarza, Jesús Cebollada, M Civera-Andrés, J I Cuende Melero, J L Díaz-Díaz, J Fernández Pardo, C Guijarro, C Jericó, M Laclaustra, C Lahoz, J López-Miranda, S Martínez-Hervás, O Muñiz-Grijalvo, J A Páramo, V Pascual, J Pedro-Botet, P Pérez-Martínez, N Plana, J Puzo, M Á Sánchez Chaparro, L Vila
One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk...
May 2022: Clínica e Investigación en Arteriosclerosis
https://read.qxmd.com/read/34906541/proprotein-convertase-subtilisin-kexin-type-9-inhibitors-in-secondary-prevention-of-vascular-events-in-patients-with-stroke-consensus-document-and-practice-guidance
#16
A Gil-Núñez, J Masjuan, J Montaner, M Castellanos, T Segura, P Cardona, J I Tembl, F Purroy, J Arenillas, E Palacio
INTRODUCTION: Patients with history of stroke or transient ischaemic attack present considerable risk of future vascular events. Reducing levels of low-density lipoprotein (LDL) cholesterol decreases the incidence of new vascular events, although in a substantial number of patients, the currently available lipid-lowering therapies fail to achieve the therapeutic goals recommended in clinical guidelines. The aim of this consensus statement is to provide updated information on the role of the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors alirocumab and evolocumab in the secondary prevention of vascular events in patients with history of ischaemic stroke...
December 11, 2021: Neurología
https://read.qxmd.com/read/34826331/-postural-control-and-gait-changes-in-subacute-stroke-patients-after-receiving-interdisciplinary-rehabilitation-and-related-factors-a-retrospective-study
#17
JOURNAL ARTICLE
A Arranz-Escudero, P Martín-Casas, M J Díaz-Arribas, E Carpio-Calatayud, G Niño-Díaz, I López-de-Uralde-Villanueva
INTRODUCTION: Although early post-stroke rehabilitation is essential to optimize recovery, its effects and prognostic factors are yet under discussion. OBJECTIVE: To assess postural control and gait changes in post-stroke patients who underwent interdisciplinary rehabilitation in subacute phase and evaluate potential associated factors. PATIENTS AND METHODS: An observational retrospective study that analyzed sociodemographic and clinical data, including Trunk Impairment Scale (TIS), Postural Assessment Scale for Stroke (PASS), Functional Ambulatory Categories (FAC) and Tinetti scale, at admission and two months after rehabilitation...
December 1, 2021: Revista de Neurologia
https://read.qxmd.com/read/34742470/medium-long-term-evaluation-of-lipid-profile-after-bariatric-surgery-gastric-bypass-versus-sleeve-gastrectomy
#18
JOURNAL ARTICLE
Laura Abellán Garay, María Inmaculada Navarro García, Rafael González-Costea Martínez, Nuria María Torregrosa Pérez, José Luis Vázquez Rojas
INTRODUCTION: Bariatric surgery aims to reduce weight and resolve the comorbidities associated with obesity. Few studies have assessed mid/long-term changes in lipid profile with sleeve gastrectomy versus gastric bypass. This study was conducted to assess and compare changes in lipid profile with each procedure after 60 months. METHODS: This was an observational, retrospective study of analytical cohorts enrolling 100 patients distributed into two groups: 50 had undergone gastric bypass (GBP) surgery and 50 sleeve gastrectomy (SG) surgery...
June 2021: Endocrinología, diabetes y nutrición
https://read.qxmd.com/read/34674985/real-life-effect-on-the-control-of-risk-factors-associated-with-initiation-of-the-cardiovascular-polypill-created-from-equipotent-drugs
#19
JOURNAL ARTICLE
M Portela-Romero, S Cinza-Sanjurjo, P Conde-Sabarís, M Rodríguez-Mañero, P Mazón-Ramos, D Rey-Aldana, J R González-Juanateyc
OBJECTIVE: This work aims to analyze the impact of Spain's National Center for Cardiovascular Research (CNIC-Ferrer)'s cardiovascular (CV)-polypill on blood pressure (BP) and low-density lipoprotein cholesterol (cLDL) levels in patients in our healthcare area who previously took equipotent doses of statins and antihypertensives. MATERIAL AND METHODS: All patients in our healthcare area (Santiago de Compostela, Spain) who, as of December 31, 2019, had an active prescription for the CV-polypill (CNIC-Ferrer) since January 16, 2015 were registered...
October 18, 2021: Revista Clínica Espanõla
https://read.qxmd.com/read/34330545/diabetes-mellitus-and-cardiovascular-risk-an-update-of-the-recommendations-of-the-diabetes-and-cardiovascular-disease-working-group-of-the-spanish-society-of-diabetes-sed-2021
#20
Francisco Arrieta, Juan Pedro-Botet, Pedro Iglesias, Juan Carlos Obaya, Laura Montanez, Gonzalo Fernando Maldonado, Antonio Becerra, Jorge Navarro, J C Perez, Romina Petrecca, José Luis Pardo, Josep Ribalta, Víctor Sánchez-Margalet, Santiago Duran, Francisco Javier Tébar, Manuel Aguilar
This document is an update to the clinical practice recommendations for the management of cardiovascular risk factors (CVRF) in diabetes mellitus. The consensus has been developed by a multidisciplinary team made up of members of the Cardiovascular Risk Group of the Spanish Diabetes Society (SED). The work is a necessary update as, since the last review three years ago, there have been many clinical trials that have studied the cardiovascular outcomes of numerous drugs in the diabetic population. We believe that this guideline update may be of interest to all clinicians treating patients with diabetes...
2022: Clínica e Investigación en Arteriosclerosis
keyword
keyword
109537
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.